Business Context and Reporting Period
Runway Growth Finance Corp. (RWAY) is an externally managed, non-diversified, closed-end management investment company regulated as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on providing senior secured loans to high-growth companies in technology, healthcare, business services, and financial services. This report covers the quarterly period ended September 30, 2025.
Key Financial Metrics
| Metric | Q3 2025 (Three Months) | Q3 2024 (Three Months) | YTD 2025 (Nine Months) | YTD 2024 (Nine Months) |
|---|---|---|---|---|
| Total Investment Income | $36.7 million | $36.7 million | $107.3 million | $110.9 million |
| Net Investment Income | $15.7 million | $15.9 million | $45.3 million | $49.1 million |
| Net Realized Gain (Loss) | ($1.3 million) | $0 | $3.2 million | $0 |
| Net Change in Unrealized Gain (Loss) | ($6.4 million) | $9.2 million | ($21.8 million) | ($3.7 million) |
| Net Increase in Net Assets from Operations | $8.0 million | $25.0 million | $26.7 million | $45.4 million |
| Net Asset Value (NAV) per Share | $13.55 | $13.79 (Dec 31, 2024) | $13.55 | $13.39 (Sep 30, 2024) |
| Total Debt Outstanding | $450.3 million | $558.3 million (Dec 31, 2024) | $450.3 million | $558.3 million (Dec 31, 2024) |
| Cash and Cash Equivalents | $7.9 million | $5.8 million (Dec 31, 2024) | $7.9 million | $5.8 million (Dec 31, 2024) |
| Portfolio Turnover Rate (YTD) | 10.64% | 14.20% | 10.64% | 14.20% |
Material Changes vs. Prior Period
- Investment Income: Remained flat for the quarter ($36.7M) but decreased year-to-date by $3.6M compared to 2024, primarily due to decreased interest income from falling interest rates.
- Unrealized Losses: The company recorded a significant net unrealized loss of $21.8 million for the nine months ended September 30, 2025, compared to a loss of $3.7 million in the prior year. This was driven by a release of prior unrealized gains on Gynesonics, Inc. and fair value decreases in JobGet Holdings, Marley Spoon SE, and Blueshift Labs.
- Debt Reduction: Total debt decreased from $558.3 million at year-end 2024 to $450.3 million at September 30, 2025. The company repaid the December 2026 Notes ($70M) and August 2027 Notes ($20M) in April 2025 and issued $107M in April 2028 Notes.
- Portfolio Composition: The portfolio fair value decreased from $1.077 billion to $946.0 million. Senior secured loans remain the dominant asset class at 90.7% of the portfolio.
Guidance, Outlook, and Material Events
- Merger Agreement: On October 9, 2025, the company entered into a definitive agreement to merge with SWK Holdings Corporation (SWK). The transaction involves a series of mergers where SWK stockholders will receive RWAY common stock or cash based on an exchange ratio of NAVs. A Key Stockholder Agreement was also signed with a holder of ~70% of SWK stock.
- Share Repurchases: The company exhausted its Third Repurchase Program ($15M) and initiated a Fourth Repurchase Program ($25M). Through September 30, 2025, it repurchased 1.21 million shares for $12.5 million under the new program.
- Distributions: The Board declared a quarterly distribution of $0.33 per share on November 5, 2025, payable December 3, 2025. YTD 2025 distributions totaled $39.5 million.
- Asset Quality: As of September 30, 2025, 64.4% of the debt portfolio was rated "2" (performing at plan), while 21.4% was rated "3" (performing below plan). One investment, Mingle Healthcare Solutions, Inc., remains on non-accrual status.
- Management Commentary: Management noted that operating expenses increased slightly year-to-date due to administration and tax expenses, offset by lower interest costs. The company maintains sufficient liquidity with $371.9 million available, including $364.0 million under its Credit Facility.
Investor Verification Checklist
- Merger Terms: Verify the final exchange ratio and cash consideration details for the SWK merger, as these depend on the NAV calculations at the Determination Date.
- Unrealized Loss Drivers: Review the specific valuation adjustments for JobGet Holdings, Marley Spoon SE, and Blueshift Labs to understand the magnitude of the $21.8M unrealized loss.
- Debt Maturity Profile: Confirm the repayment schedule for the $25M April 2026 Notes due within the next year and the refinancing strategy for the $186M Credit Facility maturing in 2029.
- Non-Accrual Status: Monitor the status of Mingle Healthcare Solutions, Inc. (0.25% of portfolio) and any potential future credit downgrades in the "3" rated category (21.4% of portfolio).
- Share Count Impact: Assess the dilution or accretion impact of the SWK merger on the current 36.1 million shares outstanding.